TP53 and hepatocellular carcinoma: Ye S., Zhao X.Y., Hu X.G., Li T., Xu Q.R., Yang H.M., Huang D.S.,Yang L. TP53 and RET may serve as biomarkers of prognosticevaluationand targeted therapy in hepatocellular carcinoma.